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Abstract
 .The expression of isoform-specific dihydropyrine receptor–calcium channel DHPR a1-subunit genes was investigated
 .  .in mdx and control mouse diaphragm DIA and tibialis anterior TA . RNase protection assays were carried out with a rat
DHPR cDNA probe specific for skeletal muscle and a mouse DHPR cDNA probe specific for cardiac muscle. The level of
expression of the gene encoding the cardiac DHPR was very weak in TA muscle from both control and mdx mice.
Compared to TA, DIA expressed mRNA for the cardiac isoform at significantly higher levels, but mdx and control mouse
DIA levels were similar to one another. In contrast, mRNA expression levels for the DHPR skeletal muscle isoform were
lower in control DIA than TA. However, there was a dramatic increase in the expression for the DHPR skeletal muscle
isoform in mdx DIA compared with control DIA, reaching the TA expression level, whereas dystrophy did not affect TA
w3 xexpression. H -PN200-110 binding was used to further assess DIA DHPR expression at the protein level. The density of
binding sites for the probe was not significantly affected in DIA muscles of mdx vs. control mice, but it was reduced in
older mdx and control mice. The increase in DHPR mRNA levels without a consequent increase in DHPR protein
expression could be secondary to possible enhanced protein degradation which occurs in mdx DIA. The altered DHPR
expression levels found here do not appear to be responsible for the severe deficits in contractile function of the mdx DIA.
q 1997 Elsevier Science B.V.
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1. Introduction
 .Duchenne Muscular Dystrophy DMD is a fatal
human disorder due to an X-linked deficiency of the
plasma membrane-associated protein dystrophin. The
mdx mouse presents the same complete deficit in
dystrophin as in DMD, due to a missense point
)  .Corresponding author. Fax: 409 772 3381; E-mail:
philip.palade@utmb.edu
w xmutation in the dystrophin gene 1 , and is usually
used as a DMD animal model, even though hind limb
muscles from mdx mice do not exhibit the progres-
sive weakness observed in DMD patients. However,
 .diaphragm muscle DIA in mdx mice has been
shown to exhibit a pattern of degenerationrregenera-
tion, fibrosis and severe functional deficit in the way
of decreased tension generation similar to that of
DMD limb muscles, but unlike mdx hindlimb mus-
w xcles 2–4 . Thus, DIA of mdx mice represents a more
0925-4439r97r$19.00 q 1997 Elsevier Science B.V. All rights reserved.
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suitable model for investigating the pathophysiology
of muscular dystrophy than mdx hindlimb muscles.
Although controversies still exist as to whether there
are real changes in intracellular calcium in muscles
w xfrom mdx mice, increases in total calcium 5–7 and
w 2qx . w xin resting intracellular free calcium Ca 8–11i
have been reported in both DMD patients and mdx
w 2qxmice. The Ca rise may result from increasedi
Ca2q influx via leak channels, possibly affected by
w xmuscle protein degradation 12 . Sarcoplasmic reticu-
 . 2qlum SR Ca pump alterations in mdx muscle
fibers have been recently reported which could also
w xbe involved 13 . However, other mechanisms regu-
lating Ca2q homeostasis of skeletal muscle fibers
may also be involved.
Two Ca2q channels play a major role in skeletal
muscle, specifically in the excitation–contraction
 .EC coupling mechanism: the dihydropyridine recep-
 .tor–calcium channel DHPR present in the trans-
 .verse tubule and the ryanodine receptor RyR of the
SR terminal cisternae. The DHPR is an oligomeric
w xcomplex composed of five protein subunits 14 . The
170 kDa a1-subunit serves as a voltage sensor which
induces Ca2q release from the SR via activation of
w x 2qthe RyR 15 , and also as an L-type Ca channel
w x16–19 . In normal skeletal muscle, DHPR activation
may not result in significant Ca2q entry during an
action potential because of the slow activation kinet-
w x 2qics of the channel 20,21 . However, Ca entry
might accompany trains of action potentials as during
a tetanus, and it has been suggested that dystrophic
muscle calcium overload could result from an in-
crease in the number or activity of voltage-dependent
2q w xCa channels 22 . Furthermore, we have recently
reported that skeletal muscle regeneration after acute
w xinjury modifies the expression of the DHPR 23 in
such a way that mRNA encoding the cardiac DHPR
was upregulated. It is now well known that in heart,
the main trigger of the Ca2q release from the SR is
2q w xCa entry through the cardiac DHPR 24,25 . This
raises the question of whether an increased content of
w 2qxCa in mdx skeletal muscle, particularly in thei
severely damaged mdx DIA, might be related to
voltage-dependent Ca2q channels of the transverse
tubules affected by the dystrophic process or the
muscle regeneration associated with it.
Levels of the cardiac or skeletal DHPR or their
message in mdx mouse skeletal muscle have not
been examined previously. With regard to human
DMD muscle, no studies of message levels have been
performed. The density of DHPRs assessed by both
w3 xH -PN200-110 binding and I density were in-Ca
creased in a cell line cultured from DMD muscle
compared to a control cell line derived from normal
w xhuman muscle 26 , but no differences were reported
w3 xin H -PN200-110 binding in biopsied muscle from
DMD patients relative to muscle from control pa-
w xtients 27 . In the present study, we investigate the
possibility that quantitative modification in the ex-
pression of the mRNA encoding the a1-subunits of
the two DHPR isoforms takes place in mdx mouse
DIA compared with control mouse DIA. In order to
determine whether effects were correlated with the
more severe functional impairment in mdx DIA, we
performed identical experiments with mdx and con-
 .trol mouse tibialis anterior TA muscle. In addition,
w3 xwe carried out H -PN200-110 binding experiments
to assess possible changes in DHPR expression at the
protein level.
2. Materials and methods
2.1. Animals
Experiments were carried out on DIA and TA
muscles from 9–11 week old mdx and control
C57BLr6 mice. In TA muscle from mdx mice, the
percentage of necrotic and regenerating fibers has
been shown to be about 1% and 0.5% respectively
w x28 . Massive growth of the endomysial and per-
imysial connective tissue is a characteristic feature of
muscle damage, and a central location of myonuclei
is usually considered a marker of fiber regeneration
w x29 . In mdx DIA muscle, 35% of the fibers have
centrally placed nuclei, but connective tissue ele-
w xments are still minimal 30 . Dihydropyridine binding
determinations were additionally carried out on DIA
of mice )65 weeks of age. At this age, mdx DIA is
characterized by fibrosis with adipose tissue replace-
w xment 30 . Animals were heavily anesthetized by
 .Pentobarbital sodium Abbott, Chicago, IL , and
muscles were removed for RNA isolation. In certain
animals, the heart was also removed for the same
purpose.
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2.2. cDNAs for mRNA analysis
The cDNAs used as hybridization probes were as
 .  .follows: 1 a rat 201 bp cDNA clone 1fb corre-
sponding to part of the repeat I of the skeletal DHPR
a1-subunit, to nucleotides 758–958 of the rabbit
sequence, specific for the skeletal muscle isoform
w x  .  .31 . 2 a mouse 152 bp cDNA clone C32 corre-
sponding to the cytoplasmic loop linking repeats II
and III of the cardiac isoform of the DHPR a1-sub-
unit. This cDNA was subcloned in the Pst I site of a
pBluescript vector from a 928 bp cDNA kindly pro-
vided by Dr. N. Chaudhari, specific for the cardiac
isoform of the DHPR and corresponds to nucleotides
244–394 of that clone GenBank, Acc number a
. w xL06233 32 . This interrepeat region shows consider-
able dissimilarity between the cardiac and skeletal
w x  .muscle calcium channels in rabbit 33 . 3 a rat
 .cDNA probe for GAPDH Ambion, Austin, TX was
used as internal marker.
2.3. RNA isolation
Total cellular RNA was isolated separately from
each muscle sample using the classical guanidinium
isothiocyanate method RNAzol B kit, Biotecx,
.Houston, TX . The amount of RNA was estimated by
ultraviolet absorption, and the ratio of absorbance at
260 nm to that at 280 nm was checked. Typically,
50 mg of total RNA was obtained from 50 mg of
tissue. Lack of degradation of RNA samples was
monitored by the observation of appropriate 28–18S
ribosomal RNA ratios as determined by ethidium
bromide staining of the agarose gels.
( )2.4. Ribonuclease protection assay RPA
Antisense RNA probes were produced using T7
 .polymerase Stratagene, La Jolla, CA on linearized
1fb, C32, GAPDH or actin templates in the presence
w 32 x  .of a- P rUTP DuPont NEN, Boston, MA . RPAs
were carried out using the RPA II Kit Ambion,
.Austin, TX , hybridizing 10–30 mg of total RNA
from each tissue source to 0.5–1=105 cpm of the
RNA probe. The RNA was run on a 5% polyacryl-
amide, 8 M urea gel. Undigested RNA probes were
also run on the same gel to be used as size marker.
However, they have a bigger size than the protected
fragments since a portion of the vector upstream of
the insert was included. Gels were exposed at y808C
on X-ray films X-OMAT, AR, Eastman Kodak,
.Rochester, NY with two intensifying screens for 2 h
in the case of the skeletal DHPR and 20 h in the case
of the cardiac DHPR.
Autoradiograms of RPAs were subjected to
densitometric analysis using the Lynx Densitometer
program They Lynx 5000 Digital Imaging Analysis
.System . The intensity of hybridization of RNAs to
the cRNA probe for GAPDH was also used to assess
possible RNA degradation. However, it was not used
for quantification as expression of the gene encoding
w xGAPDH depends on the kind of muscles 34 , with
greater expression in EDL than SOL and a decrease
in expression upon chronic stimulation or denervation
w xPereon, unpublished results . Each data point pre-´ ´
sented in the results represents data from at least
three separate experiments. Data are expressed as
mean values " SD. The statistical significance of
differences in mean values between mRNA levels
was assessed by the unpaired t-test. A p-0.05 level
was considered to be significant.
[3 ]2.5. H -PN200-110 binding
DIA muscles were dissected from mdx and control
mice, frozen in liquid nitrogen and stored at y808C
until used. For each preparation, the muscle from a
single animal was used. DIA homogenates were ob-
tained by homogenization in 8 vols 0.1 M NaCl,
2 mM EDTA, 0.2 mM EGTA, 5 mM Tris–maleate,
pH 6.8 in the presence of 0.2 mM PMSF, 1 mM
leupeptin, 1 mM pepstatin and 1 mM iodoacetamide
using a Tissue Tearor BioSpec Products, Bartlesville,
.OK . Samples were incubated at 2 mg wet wt of
w3 xmuscle in 2 ml with 0.05–5 nM H -PN200-110
 .Dupont NEN, Boston, MA for 1 h at room tempera-
ture in 50 mM Tris–Cl, pH 7.5 supplemented with
10 mM CaCl and 5mM leupeptin. Membrane bound2
w3 xH -PN200-110 was determined in duplicate by fil-
tration through 0.05% polyethylenimine-presoaked
25 mm glass fiber filters GFrB, Whatman, Kent,
.England . Filters were rinsed 3 times with 5 ml of
ice-cold 50 mM Tris–Cl, pH 7.5 and analyzed in a
w3 xscintillation counter. Nonspecific H -PN200-110
binding was assessed in the presence of 1 mM unla-
belled nifedipine and subtracted. Binding data was
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Fig. 1. Expression of mRNA for the cardiac isoform of the
DHPR a1-subunit in control and mdx TA, DIA and in control
heart. Representative RNase protection assays demonstrating
presence of the expected 152bp protected fragment in DIA, and a
weak signal in TA. Heart: control mouse heart total RNA used as
a positive control. 20–30 mg of total RNA were hybridized with
radiolabeled single strand antisense RNA probes cardiac DHPR
.and GAPDH . Undigested full length probes were used as size
 .markers not shown .
analyzed using the ligand binding to one site option
of ENZFITTER Elsevier-Biosoft, Cambridge, Eng-
.land . Goodness of fit was additionally checked visu-
ally both in this plot mode as well as in transforma-
tions to Scatchard plots.
3. Results and discussion
3.1. Expression le˝els of cardiac DHPR–calcium
channel mRNA in DIA and TA from control and mdx
mice
20–30 mg of total RNA from control and mdx
mouse DIA, TA and heart were hybridized to the
cRNA probe corresponding to the 152 bp fragment of
the cardiac a1-subunit cDNA, and at the same time
to the cRNA probe corresponding to the GAPDH
cDNA. In skeletal muscle from both control and mdx
mouse, we detected the transcript specific for the
 .cardiac DHPR a1-subunit Fig. 1 . Similar results
were obtained in 3 separate preparations of total
RNA. As expected, the level of expression of the
gene encoding the cardiac isoform of the DHPR was
very weak in TA muscle from control and mdx
mouse 3.9"1.6% and 3.5"0.6% of the level of
.  .heart expression, respectively, N.S. Fig. 2 . To our
surprise, we found that DIA from both mdx and
control mice express significantly higher levels of the
 .  .Fig. 2. Relative expression level of the cardiac muscle A and the skeletal muscle B isoforms of the DHPR–calcium channel in control
and mdx mice DIA and TA. Quantification of autoradiograms was performed by densitometry according to the amount of total RNA.
 .  .Data were expressed as percentage of control mouse heart A or TA B expression. Each data point represents the mean of at least three
 .independent experiments. Errors bars represent SD. A: p-0.01 for DIA vs. TA ‡ , control or mdx. B: p-0.01 for mdx DIA vs.
 .  .control DIA )) , or control DIA vs. control TA ) .
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cardiac isoform of the DHPR than either mdx or
 .control TA p-0.01 , but that its expression in mdx
DIA was no higher than in control DIA. The stan-
dardized intensity of the hybridization signal reached
similar values in control and mdx mouse DIA con-
trol: 9.1"3.8%; mdx: 7.7"0.8% of the level of
.heart expression, N.S. . Transient expression of
mRNA for the cardiac isoform of the DHPR has been
observed during the initial stages of skeletal muscle
w xregeneration in rat EDL 23 . However, it should be
emphasized that this expression mainly takes place 3
days after the beginning of regeneration induced by
bupivacaine injection, when 84% of the muscle was
composed of colonies of myotubes, mainly with cen-
w xtral myonuclei 35 . The mdx DIA undergoes a
necrosis-regeneration process which starts 3–4 weeks
after birth and goes on repetitively in DIA. At any
one time, little regeneration is taking place Section
.2.1 and enhanced expression of the cardiac DHPR
due to regeneration might be difficult to observe.
3.2. Expression le˝els of skeletal DHPR–calcium
channel mRNA in DIA and TA muscles from control
and mdx mice
10 mg of total RNA from control or mdx mouse
DIA or TA were hybridized to the 201 bp 1fb cRNA
probe corresponding to the skeletal isoform of the
DHPR a1-subunit, and at the same time to a cRNA
probe corresponding to an internal marker cDNA
 .GAPDH . Unexpectedly the present study showed
that a dramatic increase of expression of the mRNA
encoding the skeletal DHPR occurs in mdx DIA vs.
control DIA, whereas no such increase was observed
 .in mdx TA vs. control TA Fig. 3 . The level of
expression was higher in control TA than in control
 .DIA p-0.05 , and similar in control TA, mdx TA
and mdx DIA. Similar results were obtained with 4
 .separate preparations of total RNA Fig. 2 . The
intensity of the hybridization signal from mdx DIA
total RNA represented 186.9"20.6% of the level of
the expression in control DIA total RNA p-
.0.05 mdx vs control . Since the expression level of
skeletal DHPR gene in mdx DIA reached values
close to those observed in both control and mdx TA,
it could be hypothesized that mdx DIA undergoes a
transformation toward a ‘‘faster’’ muscle, but this
seems to be unlikely. Interestingly, DIA fiber compo-
Fig. 3. Expression of mRNA for the skeletal isoform of the
DHPR a1-subunit in mouse DIA and TA. Representative RNase
protection assays demonstrating increased expression in mdx
DIA compared with control DIA, and similar expression in
control and mdx TA. Expression of skeletal DHPR is lower in
DIA than in TA. 10 mg of total RNA were hybridized with
radiolabeled single strand antisense RNA probes skeletal DHPR
.and GAPDH . The upper bands correspond to hybridized GAPDH
probe used as an internal marker, but at a higher specific activity
than in Fig. 1. Note the increased expression in GAPDH in mdx
DIA. Undigested full length probes were used as size markers
 .not shown .
sition is dependent on both species mouse, rat, rab-
. bit, cow and on a regional variability sternal, crural,
.costal with a mosaic distribution of slow- and fast-
w xtwitch fibers 36 . In the present work, great care was
taken to remove the whole DIA, and mdx and control
mouse DIA removal was performed side by side.
Histochemically, no difference in fiber type distribu-
tion between mdx and control DIA was detected in
w x30–270 day-old mice by Louboutin et al 30 . Fur-
thermore, contractile properties time course of the
. w xtwitch of mdx DIA either became slower 4 or
w xremained unchanged compared with control DIA 37 ,
intermediate between those measured in mouse soleus
w xand EDL muscle 38 .
3.3. Expression of DHPR protein in DIA muscles
from control and mdx mice
To test whether the increased mRNA levels in
mdx DIA resulted in increased numbers of functional
DHPRs, DHPR protein was quantitated in mdx and
control DIA using binding of the high-affinity probe
w3 xH -PN200-110. No significant change in the density
of DHPR protein in mdx vs control mice DIA was
observed in the present study. Analysis of binding
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data indicated the presence of similar numbers of
high-affinity sites in control and mdx muscles, with
B values of 91.4"21.5 and 98.3"9.8 pmolrgmax
wet wt for control and mdx DIA, respectively Fig.
.4, Table 1 . Our mdx mouse results are similar to
w xthose of Desnuelle et al 27 , who previously reported
that density of high affinity DHPRs was not altered
in DMD patient skeletal muscle compared to normal
adult skeletal muscle. Expression levels of a protein
 w x.do not always match its mRNA levels c.f., 39 . The
combination of increased DHPR mRNA levels unac-
companied by an equivalent increase in DHPR pro-
tein may indicate some kind of translational or pos-
translational effect. Proteolysis in general has been
w xreported increased in mdx mouse muscle 10 , and
the increased mRNA might represent a compensation
mechanism for a possible increase in DHPR break-
down. We speculate that a two-fold increase in mRNA
levels might approximately compensate for a similar
increase in rate of DHPR protein breakdown.
Finally, since there appeared to be a small but
statistically significant increase in the affinity of the
 .mdx DIA DHPRs Table 1, K column , and in partd
because functional defects in mdx DIA grow more
w xsevere with age 4 , additional experiments with older
 .mice )65 weeks old were performed. The DIA
from these older mdx mice displayed no difference in
PN200-110 binding with respect to controls with
Table 1
w3 xHigh affinity H -PN200-110 binding to control and mdx DIA.
w3 xH -PN200-110 binding assays were carried out as described in
Section 2.5. The corresponding B maximum binding capac-max
.  .ity values and K dissociation constant values were calculatedd
by Scatchard plot analysis of the experimental data. Results given
 .as means " SE of number of experiments n
n B Kmax d
 .  .pmolrg wet wt nM
Control DIA 4 91.4"10.7 1.73"0.20
 .young adult
amdx DIA 3 98.3"5.7 0.91"0.02
 .young adult
a aControl DIA 4 41.6"7.4 1.01"0.18
 .old adult
bmdx DIA 8 38.4"7.8 1.35"0.37
 .old adult
all values represent mean " SE
a  .p -0.05 vs. control DIA young adult .
b  .p -0.05 vs. mdx DIA young adult .
 .respect to either B or K values Table 1 , al-max d
though the density of binding sites was significantly
decreased in both sets of older mice. These results
suggest that DHPR density declines in older mice,
w xcontrary to a recent report for rat TA 40 , but in
w xaccord with results of Renganathan et al 41 with rat
EDL and soleus muscle. Decreases in DHPR density
could contribute to the decrease in muscle strength
Fig. 4. PN200-110 binding by control and mdx mouse DIA. Representative plots of binding data from individual diaphragms of control
 .  .mouse A and mdx mouse B are shown, with Scatchard transformation of the data shown in insets. Note that the intercepts of the
Scatchards with the ordinates are at approx. 8=101.
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found in aging, but they do not appear to account for
the reduced contractile function of mdx DIA.
Acknowledgements
We are grateful to Dr. Nirupa Chaudhari for mouse
cardiac DHPR cDNA and to Dr. Osvaldo Delbono
w xfor providing a preprint of Ref. 41 . Dr Yann Pereon´ ´
is supported by grants from the ’Ministere des Af-`
faires Etrangeres’ Paris, France, Programme`
.  .Lavoisier , the Philippe Foundation New York, NY ,
 .the ’AFCPH’ Nantes, France and NIH AR41526.
This work is part of the PhD thesis of YP.
References
w x1 A.S. Ryder-Cook, P. Sicinski, K. Thomas, K.E. Davies,
R.G. Worton, E.A. Barnard, M.G. Darlison, P.J. Barnard,
 .EMBO J. 7 1988 3017–3021.
w x2 B. Boland, B. Himpens, J.F. Denef, J.M. Gillis, Muscle
 .Nerve 18 1995 649–657.
w x3 E.E. Dupont-Versteegden, R.J. McCarter, Muscle Nerve 15
 .1992 1105–1110.
w x4 H.H. Stedman, H.L. Sweeney, J.B. Shrager, H.C. Maguire,
R.A. Panettieri, B. Petrof, M. Narusawa, J.M. Leferovich,
 .J.T. Sladky, A.M. Kelly, Nature 352 1991 536–539.
w x5 T.E. Bertorini, S.K. Bhattacharya, G.M. Palmieri, C.M.
 .Chesney, D. Pifer, B. Baker, Neurology 32 1982 1088–
1092.
w x  .6 J.B. Bodensteiner, A.G. Engel, Neurology 28 1978 439–
446.
w x  .7 J.F. Dunn, G.K. Radda, J. Neurol. Sci. 103 1991 226–231.
w x8 P. Fong, P.R. Turner, W.F. Denetclaw, R.A. Steinhardt,
 .Science 250 1990 673–676.
w x  .9 V. Sanchez, J.R. Lopez, L.E. Briceno, Biophys. J. 53 1988
438A.
w x10 P.R. Turner, T. Westwood, C.M. Regen, R.A. Steinhardt,
 .Nature 335 1988 735–738.
w x11 D.A. Williams, S.I. Head, A.J. Bakker, D.G. Stephenson, J.
 .  .Physiol. London 428 1990 243–256.
w x12 P.R. Turner, R. Schultz, B. Ganguly, R.A. Steinhardt, J.
 .Membr. Biol. 133 1993 243–251.
w x13 M.E. Kargacin, G.J. Kargacin, Biochim. Biophys. Acta 1290
 .1996 4–8.
w x  .14 W.A. Catterall, Cell 64 1991 871–874.
w x  .15 E. Rios, G. Brum, Nature 325 1987 717–720.
w x16 K.G. Beam, B.A. Adams, T. Niidome, S. Numa, T. Tanabe,
 .Nature 360 1992 169–171.
w x17 E. Perez-Reyes, H.S. Kim, A.E. Lacerda, W. Horne, X.Y.
Wei, D. Rampe, K.P. Campbell, A.M. Brown, L. Birn-
 .baumer, Nature 340 1989 233–236.
w x18 T. Tanabe, K.G. Beam, J.A. Powell, S. Numa, Nature 336
 .1988 134–139.
w x19 T. Tanabe, H. Takeshima, A. Mikami, V. Flockerzi, H.
Takahashi, A. Kangawa, M. Kojima, H. Matsuo, T. Hirose,
 .S. Numa, Nature 328 1987 313–328.
w x  .  .20 J.A. Sanchez, E. Stefani, J. Physiol. London 283 1978
197–209.
w x  .21 P.L. Donaldson, K.G. Beam, J. Gen. Physiol. 82 1983
449–468.
w x22 J.A. Wagner, I.J. Reynolds, H.F. Weisman, P. Dudeck, M.L.
 .Weisfeldt, S.H. Snyder, Science 232 1986 515–518.
w x23 Y. Pereon, J. Navarro, V. Sorrentino, J.P. Louboutin, J.´ ´
 .Noireaud, P.T. Palade, Pflug. Arch. 433 1997 221–229.
w x  .24 G. Callewaert, Cardiovasc. Res. 26 1992 923–932.
w x25 M. Nabaeur, G. Callewaert, L. Cleeman, M. Morad, Science¨
 .244 1989 800–803.
w x26 R. Caviedes, P. Caviedes, J.L. Liberona, E. Jaimovich,
 .Muscle Nerve 17 1994 1021–1028.
w x27 C. Desnuelle, J.F. Renaud, E. Delpont, G. Serratrice, M.
 .Lazdunski, Muscle Nerve 9 1986 148–151.
w x  .28 C. Pastoret, A. Sebille, J. Neurol. Sci. 129 1995 97–105.
w x29 B.Q. Banker, A.G. Engel, Basic reactions in myology, in:
 .A.G. Engel, B.Q. Banker Eds. , Myology, McGraw-Hill,
New York, 1986, pp. 845–907
w x30 J.P. Louboutin, V. Fichter-Gagnepain, E. Thaon, M. Fardeau,
 .Neuromuscular Disord. 3 1993 436–439.
w x31 S. Kandarian, S. O’Brien, K. Thomas, L. Schulte, J. Navarro,
 .J. Appl. Physiol. 72 1992 2510–2514.
w x  .32 N. Chaudhari, K.G. Beam, Dev. Biol. 155 1993 507–515.
w x33 A. Mikami, K. Imoto, T. Tanabe, T. Niidome, Y. Mori, H.
 .Takeshima, S. Narumiya, S. Numa, Nature 340 1989
230–233.
w x34 Y. Pereon, J. Navarro, M. Hamilton, F.W. Booth, P.T.´ ´
 .Palade, Biochem. Biophys. Res. Com. 235 1997 217–222.
w x35 J.P. Louboutin, V. Fichter-Gagnepain, J. Noireaud, Muscle
 .Nerve 19 1996 994–1002.
w x36 W.D. Reid, J.M. Hards, B.R. Wiggs, E.N. Wood, P.V.
 .Wright, R.L. Pardy, Muscle Nerve 12 1989 108–118.
w x37 Y. Pereon, A. Khammari, J. Noireaud, Acta Physiol. Scand.´ ´
 .158 1996 287–294.
w x  .38 J. Noireaud, C. Leoty, Exp. Neurol. 87 1985 495–502.
w x39 C. Sainte-Beuve, P.D. Allen, G. Dambrin, F. Rannou, I.
Marty, P. Trouve, V. Bors, A. Pavie, I. Gandgjibakch, D.´
 .Charlemagne, J. Mol. Cell. Cardiol. 9 1997 1237–1246.
w x40 E. Damiani, L. Larsson, A. Margreth, Cell Calcium 19
 .1996 15–27.
w x41 M. Renganathan, M.L. Messi, O. Delbono, J. Membr. Biol.
 .157 1997 247–253.
